Torthaí cuardaigh - Gustav Gaudernack
- 1 - 20 toradh as 35 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
-
2
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells de réir Jon Amund Kyte, Gustav Gaudernack
Foilsithe / Cruthaithe 2006Revisão -
3
Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal a... de réir Stein Sæbøe‐Larssen, Ellen Fossberg, Gustav Gaudernack
Foilsithe / Cruthaithe 2006Artigo -
4
K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location de réir Jarle Breivik, GI Meling, Anne Spurkland, TO Rognum, Gustav Gaudernack
Foilsithe / Cruthaithe 1994Artigo -
5
Sialomucin CD34 is the major L-selectin ligand in human tonsil high endothelial venules. de réir Kamal D. Puri, Erik B. Finger, Gustav Gaudernack, T. Springer
Foilsithe / Cruthaithe 1995Artigo -
6
Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12VAL) peptide vaccination of a patient, recognize 12VAL-dependent nested epitopes present within the vaccine pe... de réir Marianne Klemp, Jens Bjørheim, Ingvil Sæterdal, June H. Myklebust, Gustav Gaudernack
Foilsithe / Cruthaithe 1997Artigo -
7
Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination de réir Gaute L. Hansen, Gustav Gaudernack, Paal Brunsvig, Milada Cvancarova, Jon Amund Kyte
Foilsithe / Cruthaithe 2015Artigo -
8
-
9
Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001 de réir Else-Marit Inderberg-Suso, Sissel Trachsel, Kari Lislerud, Anne‐Marie Rasmussen, Gustav Gaudernack
Foilsithe / Cruthaithe 2012Artigo -
10
DEPLETION OF T LYMPHOCYTES FROM HUMAN BONE MARROW de réir Frode Vartdal, Gunnar Kvalheim, Tor Lea, Vidar Bosnes, Gustav Gaudernack, J. Ugelstad, D Albrechtsen
Foilsithe / Cruthaithe 1987Artigo -
11
Long‐term follow‐up of patients with resected pancreatic cancer following vaccination against mutant K‐ras de réir Synne Wedén, Marianne Klemp, Ivar P. Gladhaug, Mona Møller, Jon Amund Eriksen, Gustav Gaudernack, Trond Buanes
Foilsithe / Cruthaithe 2010Artigo -
12
T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces<i>in vivo</i>tumor growth de réir Else Marit Inderberg, Sébastien Wälchli, Marit Renée Myhre, Sissel Trachsel, Hilde Almåsbak, Gunnar Kvalheim, Gustav Gaudernack
Foilsithe / Cruthaithe 2017Artigo -
13
hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes de réir Else-Marit Inderberg-Suso, Svein Dueland, Anne-Marie Rasmussen, Turid Vetrhus, Steinar Aamdal, Gunnar Kvalheim, Gustav Gaudernack
Foilsithe / Cruthaithe 2011Artigo -
14
Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors de réir Jarle Breivik, Ragnhild A. Lothe, Gunn Iren Meling, Torleiv O. Rognum, Anne‐Lise Børresen‐Dale, Gustav Gaudernack
Foilsithe / Cruthaithe 1997Artigo -
15
Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation de réir Marianne Klemp, Jarle Breivik, Ingvil Sæterdal, Erik Thorsby, Gustav Gaudernack, A. Bakka, O. Søreide, Bjarte G. Solheim
Foilsithe / Cruthaithe 1995Artigo -
16
Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study de réir Stephan Bernhardt, Marianne Klemp, Dagmar S. Trachsel, Mona Møller, Jon Amund Eriksen, Maria Lettisia Meo, Trond Buanes, Gustav Gaudernack
Foilsithe / Cruthaithe 2006Artigo -
17
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients de réir Lijun Mu, Jon Amund Kyte, Gunnar Kvalheim, S. Aamdal, Svein Dueland, M. Häuser, Hege Hammerstad, Håkon Wæhre, Nils Raabe, Gustav Gaudernack
Foilsithe / Cruthaithe 2005Artigo -
18
Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial de réir Paal Brunsvig, Jon Amund Kyte, Christian Kersten, Stein Sundstrøm, Mona Møller, Marta Nyakas, Gaute L. Hansen, Gustav Gaudernack, Steinar Aamdal
Foilsithe / Cruthaithe 2011Artigo -
19
A TCR-based Chimeric Antigen Receptor de réir Even Walseng, Hakan Köksal, Ibrahim M. Sektioglu, Anne Fåne, Gjertrud Skorstad, Gunnar Kvalheim, Gustav Gaudernack, Else Marit Inderberg, Sébastien Wälchli
Foilsithe / Cruthaithe 2017Artigo -
20
Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells de réir Jon Amund Kyte, Steinar Aamdal, Svein Dueland, Stein Sæbøe-Larsen, Else Marit Inderberg, Ulf Madsbu, Eva Skovlund, Gustav Gaudernack, Gunnar Kvalheim
Foilsithe / Cruthaithe 2016Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biology
Immunology
Medicine
Immune system
Cancer
Gene
Internal medicine
Antigen
Cancer research
Immunotherapy
Genetics
Oncology
Biochemistry
In vitro
T cell
Cell biology
Telomerase
Melanoma
Mutation
Clinical trial
Cytotoxic T cell
Epitope
Gastroenterology
Stem cell
Vaccination
CD8
Colorectal cancer
Lung cancer
Molecular biology
Allele